2-methylcitric acid has been researched along with Liver Neoplasms in 1 studies
2-methylcitric acid: RN given refers to parent cpd
Liver Neoplasms: Tumors or cancer of the LIVER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sun, J | 3 |
Ding, J | 3 |
Shen, Q | 3 |
Wang, X | 3 |
Wang, M | 3 |
Huang, Y | 3 |
Zhang, X | 3 |
Zhu, H | 3 |
Zhang, F | 3 |
Wu, D | 3 |
Peng, M | 3 |
Zhang, Z | 3 |
Yuan, Y | 3 |
Li, W | 3 |
She, ZG | 3 |
Zhang, XJ | 3 |
Li, H | 3 |
Zhang, P | 3 |
Huang, Z | 3 |
1 other study available for 2-methylcitric acid and Liver Neoplasms
Article | Year |
---|---|
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Carnitine; Citrate (si)-Synthase; Humans; Liver Neoplasms; Mice | 2023 |